Trial
NCT04864522
Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Virginia
Collaborators
—
Condition
Multiple Myeloma
Intervention
SLAMF7 FPBMC
Why stopped
Slow accrual due to a crowded field of effective drugs by the time the study opened
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-21